FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
SPOTLIGHT:
FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers
The annual New Drug Therapy Approvals report is out! In 2023, CDER approved 55 novel drugs, targeting a wide range of disease areas & more than half of the novel drugs approved in 2023 were approved to prevent, diagnose or treat a rare disease or condition.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Enhances Global Patient and Regulatory Collaborations in Oncology
Feb. 1 Virtual Discussion to Highlight Successes from Development to Approval
FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers
CDER approved a wide range of therapies in 2023 that will help patients and consumers live better and possibly longer lives.
Some table information
| Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
|---|